Analyze Diet

Topic:Moxidectin

Moxidectin is an anthelmintic agent used in horses for the control and treatment of various parasitic infections, particularly those caused by nematodes. It belongs to the macrocyclic lactone class of drugs and is known for its efficacy against a broad spectrum of parasites, including strongyles and bots. Moxidectin works by disrupting the nerve transmission in parasites, leading to paralysis and eventual death of the target organisms. Its pharmacokinetic properties allow for extended protection against re-infection, making it a valuable component in equine parasite management programs. This page compiles peer-reviewed research studies and scholarly articles that explore the pharmacodynamics, safety, efficacy, and resistance patterns associated with moxidectin use in horses.
A national survey of anthelmintic resistance in ascarid and strongylid nematodes in Australian Thoroughbred horses.
International journal for parasitology. Drugs and drug resistance    November 29, 2023   Volume 24 100517 doi: 10.1016/j.ijpddr.2023.11.006
Abbas G, Ghafar A, McConnell E, Beasley A, Bauquier J, Wilkes EJA, El-Hage C, Carrigan P, Cudmore L, Hurley J, Gauci CG, Beveridge I, Ling E....This study quantified the extent of anthelmintic resistance (AR) in ascarid and strongylid nematodes against commonly used anthelmintics in Australian Thoroughbred horses. Faecal egg count reduction tests (FECRTs, n = 86) and egg reappearance period (ERP) tests were conducted on 22 farms across Australia. Faecal egg counts (FECs) were determined using the modified McMaster technique, and percent faecal egg count reduction (%FECR) was calculated using the Bayesian hierarchical model and hybrid Frequentist/Bayesian analysis method. The results were interpreted using old (published in 1992) and...
Alleviating lesions of chronic progressive lymphedema in Belgian draft horses by successfully treating Chorioptes bovis infestation with moxidectin 0.5% pour-on.
Veterinary parasitology    November 10, 2023   Volume 324 110074 doi: 10.1016/j.vetpar.2023.110074
Brys M, Claerebout E, Chiers K.The aim of this prospective, randomized, single-blinded, and placebo-controlled clinical trial was to investigate the efficacy of a moxidectin pour-on solution for the treatment of Chorioptes bovis infestation in Belgian draft horses, and in addition, to evaluate the effect of this treatment on the clinical signs and lesions associated with chronic progressive lymphedema (CPL). Nineteen privately owned Belgian draft horses were randomly assigned to either a treatment group (moxidectin pour-on formulation, n = 10) or a placebo group (phosphate-buffered saline (PBS), n = 9). On Day 0, all 19...
Perspectives on the utility of moxidectin for the control of parasitic nematodes in the face of developing anthelmintic resistance.
International journal for parasitology. Drugs and drug resistance    June 15, 2019   Volume 10 69-83 doi: 10.1016/j.ijpddr.2019.06.002
Prichard RK, Geary TG.Macrocyclic lactone (ML) anthelmintics are the most important class of anthelmintics because of our high dependence on them for the control of nematode parasites and some ectoparasites in livestock, companion animals and in humans. However, resistance to MLs is of increasing concern. Resistance is commonplace throughout the world in nematode parasites of small ruminants and is of increasing concern in horses, cattle, dogs and other animals. It is suspected in Onchocerca volvulus in humans. In most animals, resistance first arose to the avermectins, such as ivermectin (IVM), and subsequently to...
In vitro evaluation of ivermectin, moxidectin, albendazole and pyrantel against cyathostomins of horses. Molento MB, Canever RJ.Cyathostomins are the most prevalent nematodes of horses, and multidrug resistance has been reported worldwide. There is a need to implement alternative drug monitoring analytical tests. The objective of this study was to determine the consistency (5 repetitions) of the larval migration on agar test (LMAT) using ivermectin, moxidectin, pyrantel or albendazole against cyathostomin infective-stage larvae in eight different concentrations. LMAT showed a strong coefficient of determination (R2 > 0.91), between the test repetitions (n=5). The average 50% effective concentration (EC50) for iverme...
Efficacy of moxidectin and an ivermectin-praziquantel combination against ascarids, strongyles, and tapeworms in Thoroughbred yearlings in field tests on a farm in Central Kentucky in 2016.
Veterinary parasitology, regional studies and reports    March 20, 2017   Volume 8 123-126 doi: 10.1016/j.vprsr.2017.03.006
Lyons ET, Bellaw JL, Dorton AR, Tolliver SC.Field tests were performed on Thoroughbred yearlings (n=143), evaluating efficacy of moxidectin (MOX) against ascarids and strongyles and the efficacy of an ivermectin (IVM)-praziquantel (PRAZ) combination against those nematodes and tapeworms on a farm in Central Kentucky. The study was started on March 1, 2016 and completed on August 23, 2016. Fecal samples were collected from yearlings every two weeks for counts of ascarid and strongyle eggs per gram of feces (EPGs) and for determining the presence of tapeworm eggs. MOX was given to 88 yearlings on March 1; 55 yearlings were nontreated cont...
Strongyle egg reappearance period after moxidectin treatment and its relationship with management factors in UK equine populations.
Veterinary parasitology    February 21, 2017   Volume 237 70-76 doi: 10.1016/j.vetpar.2017.02.018
Tzelos T, Barbeito JS, Nielsen MK, Morgan ER, Hodgkinson JE, Matthews JB.Parasitic nematodes, particularly cyathostomins, are ubiquitous in grazing horses world-wide. Considerable burdens of cyathostomin larvae can encyst in the large intestinal wall. The most recommended treatment against these pathogenic stages is moxidectin. Information is required on how effective moxidectin is against cyathostomin populations in different regions. The objectives here were to determine the efficacy of moxidectin treatment and estimate the strongyle egg reappearance period (ERP) after treatment in several equine populations, to confirm the type of strongyle nematodes present and...
Time required by different anthelmintics to reach expected efficacy levels in horses infected by strongyles.
Veterinary parasitology    October 4, 2016   Volume 229 90-92 doi: 10.1016/j.vetpar.2016.10.002
Saes IL, Vera JHS, Fachiolli DF, Yamada PH, Dellaqua JVT, Saes RL, Amarante AFT, Soutello RVG.The aim of this study was to determine the time required by different anthelmintic agents to reduce strongyle egg shedding in horses. Fifty horses were divided into five homogenous groups based on faecal egg counts (FECs). Treatment groups received either ivermectin; moxidectin; fenbendazole; piperazine; or no treatment (control group). Faecal examinations were performed 4, 8, 12, 18, 24, 36 and 48h after the anthelmintic treatment. After this period, faecal samples were taken every 24h over the next 12days and finally on alternate days (48-h intervals) for another 14days until the end of the ...
Species composition of larvae cultured after anthelmintic treatment indicates reduced moxidectin susceptibility of immature Cylicocyclus species in horses.
Veterinary parasitology    July 26, 2016   Volume 227 77-84 doi: 10.1016/j.vetpar.2016.07.029
Kooyman FN, van Doorn DC, Geurden T, Mughini-Gras L, Ploeger HW, Wagenaar JA.For the control of cyathostomins in horses, the macrocyclic lactones (MLs), moxidectin (MOX) and ivermectin (IVM) are the most commonly used anthelmintics. However, reduced activity, observed as shortening of the egg reappearance period (ERP) has been described. Shortening of the ERP may be caused by a decreased susceptibility of immature worms for MLs. Alternatively, immature worms may develop faster into egg producing adults as a result of repeated ML treatments. The species composition of the larval cultures obtained shortly after ML and pyrantel (PYR) treatment can confirm the hypothesis o...
Objective evaluation of two deworming regimens in young Thoroughbreds using parasitological and performance parameters.
Veterinary parasitology    March 22, 2016   Volume 221 69-75 doi: 10.1016/j.vetpar.2016.03.018
Bellaw JL, Pagan J, Cadell S, Phethean E, Donecker JM, Nielsen MK.Parasitic helminths of equids are capable of causing ill-thrift, clinical disease, and death. Although young horses are the most susceptible to parasitic disease and are the most intensively treated cohort, deworming regimens are rarely evaluated within this age group. This study objectively evaluated the impact of deworming regimen on fecal egg counts (FECs), growth rates, and body-condition scores in young Thoroughbreds. Forty-eight Thoroughbred foals from three central Kentucky farms were randomly allocated to two treatment groups: an interval dose program receiving bi-monthly rotations of ...
Comparison of the larvicidal efficacies of moxidectin or a five-day regimen of fenbendazole in horses harboring cyathostomin populations resistant to the adulticidal dosage of fenbendazole.
Veterinary parasitology    October 21, 2015   Volume 214, Issue 1-2 100-107 doi: 10.1016/j.vetpar.2015.10.003
Reinemeyer CR, Prado JC, Nielsen MK.Despite widespread acknowledgement of cyathostomin resistance to adult icidal dosages of benzimidazole (BZD) anthelmintics, many strongyle control programs continue to feature regularly scheduled larvicidal treatment with fenbendazole (FBZ). However, no studies have been conducted to evaluate the efficacy of larvicidal regimens against encysted cyathostomins in a BZD-resistant (BZD-R) population. A masked, randomized, controlled clinical study was conducted with 18 juvenile horses harboring populations of cyathostomins that were considered BZD-R on the basis of fecal egg count reduction (FECR)...
Local and systemic inflammatory and immunologic reactions to cyathostomin larvicidal therapy in horses.
Veterinary immunology and immunopathology    September 25, 2015   Volume 168, Issue 3-4 203-210 doi: 10.1016/j.vetimm.2015.09.009
Nielsen MK, Loynachan AT, Jacobsen S, Stewart JC, Reinemeyer CR, Horohov DW.Encysted cyathostomin larvae are ubiquitous in grazing horses. Arrested development occurs in this population and can lead to an accumulation of encysted larvae. Large numbers of tissue larvae place the horse at risk for developing larval cyathostominosis. This disease complex is caused by mass emergence of these larvae and is characterized by a generalized acute typhlocolitis and manifests itself as a profuse protein-losing watery diarrhea with a reported case-fatality rate of about 50%. Two anthelmintic formulations have a label claim for larvicidal therapy of these encysted stages; moxidect...
Comparison of a single dose of moxidectin and a five-day course of fenbendazole to reduce and suppress cyathostomin fecal egg counts in a herd of embryo transfer-recipient mares.
Journal of the American Veterinary Medical Association    October 7, 2014   Volume 245, Issue 8 944-951 doi: 10.2460/javma.245.8.944
Mason ME, Voris ND, Ortis HA, Geeding AA, Kaplan RM.To compare larvicidal regimens of fenbendazole and moxidectin for reduction and suppression of cyathostomin fecal egg counts (FEC) in a transient herd of embryo transfer-recipient mares. Methods: Randomized, complete block, clinical trial. Methods: 120 mares from 21 states, residing on 1 farm. Methods: An initial fecal sample was collected from each mare; mares with an FEC ≥ 200 eggs/g were assigned to treatment groups. Eighty-two horses received fenbendazole (10.0 mg/kg [4.5 mg/lb], PO, q 24 h for 5 days) or moxidectin (0.4 mg/kg [0.18 mg/lb], PO, once); FEC data were analyzed 14, 45, and 9...
Decreased strongyle egg re-appearance period after treatment with ivermectin and moxidectin in horses in Belgium, Italy and The Netherlands.
Veterinary parasitology    April 26, 2014   Volume 204, Issue 3-4 291-296 doi: 10.1016/j.vetpar.2014.04.013
Geurden T, van Doorn D, Claerebout E, Kooyman F, De Keersmaecker S, Vercruysse J, Besognet B, Vanimisetti B, di Regalbono AF, Beraldo P, Di Cesare A....The objective of the present study was to evaluate the efficacy of an oral treatment with ivermectin (IVM) or moxidectin (MOX) against gastro-intestinal strongyles in naturally infected horses by performing a faecal egg count reduction test (FECRT) and by monitoring the egg reappearance period (ERP) after treatment. Therefore, a field efficacy study with a randomised complete block design for each study site was conducted, with the individual animal as the experimental unit. At least 10 study sites in Italy, Belgium and The Netherlands were selected and animals were allocated to one of the two...
Critical tests evaluating efficacy of moxidectin against small strongyles in horses from a herd for which reduced activity had been found in field tests in Central Kentucky.
Parasitology research    August 17, 2010   Volume 107, Issue 6 1495-1498 doi: 10.1007/s00436-010-2025-5
Lyons ET, Tolliver SC, Kuzmina TA, Collins SS.Critical tests were performed in 2009 and 2010 in four 2-year-old horses naturally infected with internal parasites. The horses were from a herd (Farm MC) where reduced activity of ivermectin and moxidectin on small strongyles was demonstrated previously from EPG (eggs/gram of feces) data in field tests. Also, in critical tests in horses from the same herd, ivermectin was less effective on immature small strongyles in the lumen of the large intestine than when the drug was first marketed. The main interest in the present critical tests was to determine the efficacy of moxidectin (400 μg/kg) o...
Shortened strongyle-type egg reappearance periods in naturally infected horses treated with moxidectin and failure of a larvicidal dose of fenbendazole to reduce fecal egg counts.
Veterinary parasitology    August 2, 2010   Volume 173, Issue 3-4 349-352 doi: 10.1016/j.vetpar.2010.07.001
Rossano MG, Smith AR, Lyons ET.Deworming horses with anthelmintics that have activity against encysted small strongyle larvae (L(3) and L(4)) is a common practice in parasite control programs. The two drugs currently available for this use are moxidectin (MOX) administered in a single dose of 0.4 mg/kg and fenbendazole (FBZ) given at the larvicidal dose (10mg/kg for 5 days). Here, we report the efficacy of MOX and the larvicidal dose of FBZ for reducing counts of strongyle-type eggs per gram of feces in naturally infected horses. Fecal egg counts (FECs) of 15 yearlings were observed following deworming. On day 0, 6 of the 1...
Combined moxidectin and environmental therapy do not eliminate Chorioptes bovis infestation in heavily feathered horses.
Veterinary dermatology    July 9, 2010   Volume 22, Issue 1 17-23 doi: 10.1111/j.1365-3164.2010.00892.x
Rüfenacht S, Roosje PJ, Sager H, Doherr MG, Straub R, Goldinger-Müller P, Gerber V.Chorioptes bovis infestation is a common cause of pastern dermatitis in the horse, with a predilection in draft horses and other horses with thick hair 'feathers' on the distal limbs. The treatment of this superficial mite is challenging; treatment failure and relapse are common. Furthermore, C. bovis infestation may affect the progression of chronic pastern dermatitis (also known as chronic proliferative pastern dermatitis, chronic progressive lymphoedema and dermatitis verrucosa) in draft horses, manifesting with oedema, lichenification and excessive skin folds that can progress to verruci...
Moxidectin: a review of chemistry, pharmacokinetics and use in horses.
Parasites & vectors    September 25, 2009   Volume 2 Suppl 2, Issue Suppl 2 S5 doi: 10.1186/1756-3305-2-S2-S5
Cobb R, Boeckh A.This article reviews the current knowledge of the use of moxidectin (MOX) in horses, including its mode of action, pharmacokinetic and pharmacodynamic properties, efficacy, safety and resistance profile.Moxidectin is a second generation macrocyclic lactone (ML) with potent endectocide activity. It is used for parasite control in horses in an oral gel formulation. The principal mode of action of MOX and of other MLs is binding to gamma-aminobutyric (GABA) and glutamate-gated chloride channels. Moxidectin is different from other MLs in that it is a poor substrate for P-glycoproteins (P-gps) and ...
Anthelmintic resistance in cyathostomin populations from horse yards in Italy, United Kingdom and Germany.
Parasites & vectors    September 25, 2009   Volume 2 Suppl 2, Issue Suppl 2 S2 doi: 10.1186/1756-3305-2-S2-S2
Traversa D, von Samson-Himmelstjerna G, Demeler J, Milillo P, Schürmann S, Barnes H, Otranto D, Perrucci S, di Regalbono AF, Beraldo P, Boeckh A....A large survey was carried out in 2008 in Europe to evaluate the efficacy of fenbendazole (FBZ), pyrantel (PYR), ivermectin (IVM) and moxidectin (MOX), i.e. the major anthelmintic molecules used in current practice against cyathostomins affecting horses. A total of 102 yards and 1704 horses was studied in three countries: 60 yards and 988 horses from Italy, 22 and 396 from the UK, 20 and 320 from Germany. The survey consisted of Faecal Egg Count Reduction Tests (FECRTs) with a faecal egg count reduction (FECR) categorization of (I) resistance present if FECR <90% and the lower 95% confidenc...
Efficacy of moxidectin against cyathostomins.
The Veterinary record    July 21, 2009   Volume 165, Issue 3 91-92 doi: 10.1136/vetrec.165.3.91-a
Coles G.No abstract available
Efficacy of moxidectin against cyathostomins after long-term use in a large herd of draught horses with a high stocking density.
The Veterinary record    May 26, 2009   Volume 164, Issue 21 652-654 doi: 10.1136/vr.164.21.652
Schumacher J, Livesey L, DeGraves F, Blagburn B, Ziska S, Caldwell M, Brock K.This study was undertaken to determine whether resistance to moxidectin had developed in a large herd of draught horses, maintained on a small acreage, which had been routinely treated with moxidectin for five years. Faeces were collected for egg counts immediately before moxidectin gel was administered orally, and seven, 30, 60 and 90 days later. The faecal egg counts were significantly reduced at seven and 30 days after treatment, but were not significantly different from pretreatment counts at 60 and 90 days after treatment. There was no evidence of resistance having developed.
Parascaris equorum resistance to moxidectin?
The Veterinary record    April 15, 2008   Volume 162, Issue 15 491 doi: 10.1136/vr.162.15.491-a
Traill P.No abstract available
Parascaris equorum resistance to moxidectin?
The Veterinary record    March 25, 2008   Volume 162, Issue 12 387 doi: 10.1136/vr.162.12.387
Peaty M.No abstract available
The persistence of benzimidazole-resistant cyathostomes on horse farms in Ontario over 10 years and the effectiveness of ivermectin and moxidectin against these resistant strains.
The Canadian veterinary journal = La revue veterinaire canadienne    March 7, 2008   Volume 49, Issue 1 56-60 
Slocombe JO, Coté JF, de Gannes RV.Three clinical trials with fecal egg count reduction tests and coproculture were conducted on 2 standardbred farms in Ontario. On Farm A, the treatment groups were mebendazole and ivermectin in trial 1, and fenbendazole and moxidectin in another. On Farm B, treatment groups were mebendazole and ivermectin. All horses treated with mebendazole or fenbendazole were subsequently treated with ivermectin or moxidectin. Strongyle eggs/g feces were estimated pre- and post-treatment using the Cornell-McMaster dilution and Cornell-Wisconsin centrifugal flotation techniques. After treatment, there was no...
Assessment of serum protein electrophoresis for monitoring therapy of naturally acquired equine cyathostomin infections.
Veterinary parasitology    April 25, 2007   Volume 147, Issue 1-2 110-117 doi: 10.1016/j.vetpar.2007.03.020
Abbott JB, Mellor DJ, Love S.Serum protein electrophoresis (SPE) has previously been suggested as a means of assessing cyathostomin burdens in horses, although SPE used for that purpose is supported by little evidence. This clinical research report describes a study that objectively evaluated the use of SPE on a population of 38 horses following the administration of different anthelmintics. The population was subdivided into three groups, Groups F, M and P: 7.5 mg/kg bwt fenbendazole was administered to Group F on day -12; on day 0 0.4 mg/kg bwt moxidectin was administered to Group M and 19 mg/kg bwt pyrantel was adminis...
Parasite field study in central Kentucky on thoroughbred foals (born in 2004) treated with pyrantel tartrate daily and other parasiticides periodically.
Parasitology research    September 30, 2006   Volume 100, Issue 3 473-478 doi: 10.1007/s00436-006-0289-6
Lyons ET, Tolliver SC, Rathgeber RA, Collins SS.Foals (79), born in 2004 on three thoroughbred horse farms (C, M, and S) in central Kentucky, were fed pyrantel tartrate daily, beginning at about 3 months of age. In addition, other parasiticides [fenbendazole (FBZ), ivermectin (IVM) alone or with praziquantel (PRAZ), oxibendazole (OBZ), pyrantel pamoate (PRT), and moxidectin (MOX)] were given periodically. All treatments were administered by farm personnel. Over a 14-month period, from May 2004 to July 2005, collections (n=989) of feces were made from the foals for determination of presence of internal parasite eggs/oocysts by qualitative an...
Macrocyclic lactone-resistant Parascaris equorum on stud farms in Canada and effectiveness of fenbendazole and pyrantel pamoate.
Veterinary parasitology    September 7, 2006   Volume 145, Issue 3-4 371-376 doi: 10.1016/j.vetpar.2006.08.008
Slocombe JO, de Gannes RV, Lake MC.The aims of studies in 2002 and 2003 on three farms with 76 foals naturally infected with Parascaris equorum were to (i) identify if the nematode was resistant to ivermectin and moxidectin, and (ii) confirm the effectiveness of fenbendazole and pyrantel pamoate for the parasite. Twelve clinical trials, each with a Fecal Egg Count Reduction Test, were conducted on two Thoroughbred and one Standardbred farms in southwestern Ontario, Canada. In each trial, Parascaris eggs/g feces were estimated for each foal pre- and post-treatment using the Cornell-Wisconsin double flotation and Cornell-McMaster...
Clinical and therapeutic studies on mange in horses.
Veterinary parasitology    June 19, 2006   Volume 141, Issue 1-2 191-195 doi: 10.1016/j.vetpar.2006.04.039
Osman SA, Hanafy A, Amer SE.At Kafr El-Sheikh province, Egypt, out of 117 examined drafting horses, mites were detected in 20 (17.09%) horses. The recovered mites were 14 Chorioptes, four Psoroptes and two Sarcoptes whereas mites were not detected in four cases clinically showed typical mange lesions. Interestingly, neither the age nor the sex of the examined horses had a clear influence on the prevalence of the infection. Clinical signs observed in mange infested horses were in the form of irregular skin lesions, severe itching and sometimes biting of affected skin areas and decrease feed consumption. The skin lesions m...
Efficacy of moxidectin 2 per cent oral gel against cyathostomins, particularly third-stage inhibited larvae, in horses.
The Veterinary record    June 6, 2006   Volume 158, Issue 22 766-767 doi: 10.1136/vr.158.22.766
Bairden K, Davies HS, Gibson NR, Hood AJ, Parker LD.No abstract available
Cyathostomes in horses in Canada resistant to pyrantel salts and effectively removed by moxidectin.
Veterinary parasitology    May 8, 2006   Volume 140, Issue 1-2 181-184 doi: 10.1016/j.vetpar.2006.03.019
Slocombe JO, de Gannes RV.Clinical trials using fecal egg count reduction tests and coproculture were conducted with yearlings and mares on a farm in 1997. Fecal samples were taken from each horse to estimate the number of strongyle eggs/g feces with Cornell-Wisconsin centrifugal flotation and Cornell-McMaster dilution techniques. Eleven of 15 yearlings, which had been on a daily feeding of grain with pyrantel tartrate for 66 d were found with strongyle eggs in feces. This was the first time the in-feed medication had been used on the farm. Nine yearlings were randomised into three groups; continuation of daily pyrante...
Field studies on endoparasites of Thoroughbred foals on seven farms in central Kentucky in 2004.
Parasitology research    December 30, 2005   Volume 98, Issue 5 496-500 doi: 10.1007/s00436-005-0091-x
Lyons ET, Tolliver SC, Collins SS.Fecal samples (n=1,584) for a parasite study were collected from Thoroughbred foals (n=349), 28 to 330 days old, on seven farms in central Kentucky during 49 monthly trips from May to October, November, or December 2004. The main purpose was to determine possible drug resistance of ascarids, also of strongyles, to ivermectin (IVM) and other commercially available compounds [fenbendazole, moxidectin (MOX), oxibendazole (OBZ), and pyrantel pamoate]. In addition, interest was on prevalence of foal parasites. Qualitative data were obtained by recording presence or absence of ascarid and strongyle ...